HEalthcare Finance
08-10-2025
TrumpRx Explained: A Self-Funded Employer’s Guide to GLP-1 Savings
.png)
The GLP-1 Budget Crisis.
Ozempic, Wegovy, and Mounjaro are clinical breakthroughs for weight loss and diabetes, but they are budget-busters for employers. In a traditional insurance plan, Pharmacy Benefit Managers (PBMs) often mark these drugs up, keeping the spread and offering minimal rebates.
The Solution: Global Arbitrage & MFN Pricing.
HealCo’s Maestro OS integrates the new "Most-Favored-Nation" (often called TrumpRx) pricing principles to protect self-funded assets.
The Result
By treating pharmacy as a supply chain problem rather than an insurance problem, HealCo helps self-funded and level-funded plans provide access to these life-changing drugs without bankrupting the renewal budget.
.png)
